Evidence map›Paper›PMID 36841802›Full record

ArticleOncogenesis2023

Targeted metabolomics detects a putatively diagnostic signature in plasma and dried blood spots from head and neck paraganglioma patients.

Simone De Fabritiis, Silvia Valentinuzzi, Gianluca Piras, Ilaria Cicalini, Damiana Pieragostino, Sara Pagotto, Silvia Perconti, Mirco Zucchelli, Alberto Schena, Elisa Taschin and 9 more

Open access · goldAbstract read
In one paragraph

Article in Oncogenesis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Artificial Intelligence in Metabolomics: A Current Review.Trends in analytical chemistry : TRAC · 2024
    Article
  4. [Endothelial cells and fibroblasts mediate the microenvironmental regulatory network of carotid body paraganglioma].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2024
    Article
  5. [Advance in HIF expression and immune microenvironment in pseudohypoxic HNPGL].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2024
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

Simone De Fabritiis *Department of Medicine and Aging Sciences, "G. d'Annunzio" University of Chieti-Pescara, 66100, Chieti, Italy.ORCID http://orcid.org/0000-0001-6404-6962
Silvia Valentinuzzi *Center for Advanced Studies and Technology (CAST), 66100, Chieti, Italy.ORCID http://orcid.org/0000-0002-1561-3542
Gianluca PirasOtology and Skull Base Unit, Gruppo Otologico, 29121, Piacenza, Italy.
Ilaria CicaliniCenter for Advanced Studies and Technology (CAST), 66100, Chieti, Italy.
Damiana PieragostinoCenter for Advanced Studies and Technology (CAST), 66100, Chieti, Italy.
Sara PagottoCenter for Advanced Studies and Technology (CAST), 66100, Chieti, Italy.ORCID http://orcid.org/0000-0003-2457-6648
Silvia PercontiCenter for Advanced Studies and Technology (CAST), 66100, Chieti, Italy.
Mirco ZucchelliCenter for Advanced Studies and Technology (CAST), 66100, Chieti, Italy.
Alberto SchenaDepartment of Oncology-Hematology, Service of Anatomic Pathology, Guglielmo da Saliceto Hospital, 29100, Piacenza, Italy.
Elisa TaschinFamilial Cancer Clinic and Oncoendocrinology, Veneto Institute of Oncology, IOV-IRCCS, 35128, Padua, Italy.
Gloria Simona BerteşteanuOtology and Skull Base Unit, Gruppo Otologico, 29121, Piacenza, Italy.
Diana Liberata EspositoCenter for Advanced Studies and Technology (CAST), 66100, Chieti, Italy.
Antonio StiglianoEndocrinology, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, 00189, Rome, Italy.ORCID http://orcid.org/0000-0002-7143-0775
Vincenzo De LaurenziCenter for Advanced Studies and Technology (CAST), 66100, Chieti, Italy.
Francesca SchiaviFamilial Cancer Clinic and Oncoendocrinology, Veneto Institute of Oncology, IOV-IRCCS, 35128, Padua, Italy.
Mario SannaOtology and Skull Base Unit, Gruppo Otologico, 29121, Piacenza, Italy.
Piero Del BoccioCenter for Advanced Studies and Technology (CAST), 66100, Chieti, Italy.ORCID http://orcid.org/0000-0003-1653-2194
Fabio VerginelliCenter for Advanced Studies and Technology (CAST), 66100, Chieti, Italy. fabio.verginelli@unich.it.ORCID http://orcid.org/0000-0002-8636-2517
Renato Mariani-CostantiniCenter for Advanced Studies and Technology (CAST), 66100, Chieti, Italy. renato.mariani@unich.it.ORCID http://orcid.org/0000-0002-4440-1848
University of Chieti-Pescara · ITIstituto Oncologico Veneto · ITCarol Davila University of Medicine and Pharmacy · ROGuglielmo da Saliceto Hospital · ITSanta Maria Nuova Hospital · ITSapienza University of Rome · IT

Funding

Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) IG 2020 ID 24501
6 · The paper itself

Abstract

Head and neck paragangliomas (HNPGLs), rare chemoresistant tumors curable only with surgery, are strongly influenced by genetic predisposition, hence patients and relatives require lifetime follow-up with MRI and/or PET-CT because of de novo disease risk. This entails exposure to electromagnetic/ionizing radiation, costs, and organizational challenges, because patients and relatives are scattered far from reference centers. Simplified first-line screening strategies are needed. We employed flow injection analysis tandem mass spectrometry, as used in newborn metabolic screening, to compare the plasma metabolic profile of HNPGL patients (59 samples, 56 cases) and healthy controls (24 samples, 24 cases). Principal Component Analysis (PCA) and Partial Least Discriminant Analysis (PLS-DA) highlighted a distinctive HNPGL signature, likely reflecting the anaplerotic conversion of the TCA cycle to glutaminolysis and catabolism of branched amino acids, DNA damage and deoxyadenosine (dAdo) accumulation, impairment of fatty acid oxidation, switch towards the Warburg effect and proinflammatory lysophosphatidylcholines (LPCs) signaling. Statistical analysis of the metabolites that most impacted on PLS-DA was extended to 10 acoustic neuroma and 2 cholesteatoma patients, confirming significant differences relative to the HNPGL plasma metabolomic profile. The best confusion matrix from the ROC curve built on 2 metabolites, dAdo and C26:0-LPC, provided specificity of 94.29% and sensitivity of 89.29%, with positive and negative predictive values of 96.2% and 84.6%, respectively. Analysis of dAdo and C26:0-LPC levels in dried venous and capillary blood confirmed that dAdo, likely deriving from 2'-deoxy-ATP accumulated in HNPGL cells following endogenous genotoxic damage, efficiently discriminated HNPGL patients from healthy controls and acoustic neuroma/cholesteatoma patients on easily manageable dried blood spots.

Identifiers

PMID36841802
PMCPMC9968333
OpenAlexW4322009753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.